| BRCA2 |
P51587
|
BRCA2 DNA repair associated
|
Nucleic acid binding
|
2.4E-25 |
0.379 |
0.846 |
| CDKN2A |
P42771 Q8N726
|
cyclin dependent kinase inhibitor 2A
|
|
0.39 |
0.300 |
0.885 |
| CSF3 |
P09919
|
colony stimulating factor 3
|
|
0.38 |
0.377 |
0.885 |
| CTLA4 |
P16410
|
cytotoxic T-lymphocyte associated protein 4
|
|
0.94 |
0.369 |
0.923 |
| CTNNB1 |
P35222
|
catenin beta 1
|
|
1.00 |
0.303 |
0.885 |
| DCN |
P07585
|
decorin
|
|
0.31 |
0.457 |
0.808 |
| ERBB2 |
P04626
|
erb-b2 receptor tyrosine kinase 2
|
Kinase
|
6.0E-03 |
0.328 |
0.923 |
| EWSR1 |
Q01844
|
EWS RNA binding protein 1
|
Nucleic acid binding
|
1.00 |
0.474 |
0.692 |
| FLT1 |
P17948
|
fms related receptor tyrosine kinase 1
|
Kinase
|
1.00 |
0.419 |
0.846 |
| KIT |
P10721
|
KIT proto-oncogene, receptor tyrosine kinase
|
Kinase
|
0.98 |
0.366 |
0.808 |
| KRAS |
P01116
|
KRAS proto-oncogene, GTPase
|
Enzyme modulator
|
7.9E-04 |
0.320 |
0.923 |
| MET |
P08581
|
MET proto-oncogene, receptor tyrosine kinase
|
Kinase
|
0.97 |
0.380 |
0.846 |
| MITF |
O75030
|
melanocyte inducing transcription factor
|
|
0.98 |
0.499 |
0.808 |
| MYC |
P01106
|
MYC proto-oncogene, bHLH transcription factor
|
Transcription factor
|
1.00 |
0.344 |
0.923 |
| PALB2 |
Q86YC2
|
partner and localizer of BRCA2
|
|
3.0E-19 |
0.485 |
0.769 |
| PIK3CA |
P42336
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha
|
Kinase
|
1.00 |
0.292 |
0.923 |
| PTEN |
P60484
|
phosphatase and tensin homolog
|
Enzyme
|
0.26 |
0.305 |
0.923 |
| RET |
P07949
|
ret proto-oncogene
|
Kinase
|
1.00 |
0.392 |
0.885 |
| SOX10 |
P56693
|
SRY-box transcription factor 10
|
|
0.99 |
0.461 |
0.808 |
| TP53 |
P04637
|
tumor protein p53
|
Transcription factor
|
0.53 |
0.236 |
0.962 |
| WT1 |
P19544
|
WT1 transcription factor
|
Nucleic acid binding
|
1.00 |
0.422 |
0.808 |